ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP)

Clinical trials for ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP) explained in plain language.

Never miss a new study

Get alerted when new ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP) trials appear

Sign up with your email to follow new studies for ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New pill aims to tackle obesity and inflammation at the same time

Disease control Not yet recruiting

This early-stage trial tests an experimental oral drug, NNC6022-0004, in healthy adults and people with obesity. The study checks how safe the drug is, how the body processes it, and whether food affects its absorption. Participants receive either the drug or a placebo capsule by…

Matched conditions: ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP)

Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP)

Get alerted when new ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN (HSCRP) trials appear

New pill aims to tackle obesity and inflammation at the same time